CIK 0001672619
- Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811523849
- Phone
- +1 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,819,567
- in 6 filings, $1.2M under 10b5-1 plans
Net −$1,819,567. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-02 | Chin Mark Director | Grant or award · Stock Options (Right to Buy) | +8,500 | 8,500 | ||
| 2021-07-16 | Chin Mark Director | Purchase | +1,333,333 | $6.00 | $8.0M | 2,344,072 |
| 2021-06-29 | Chin Mark Director | Grant or award · Stock Options (Right to Buy) | +7,728 | 7,728 | ||
| 2020-03-16 | Chin Mark Director | Conversion | +1,367,058 | 1,367,058 | ||
| 2020-03-16 | Chin Mark Director | Purchase | +187,500 | $16.00 | $3.0M | 1,554,558 |
| 2020-03-16 | Chin Mark Director | Conversion · Series B Preferred Stock | −8,611,110 | 0 | ||
| 2020-03-16 | Chin Mark Director | Grant or award · Stock Option (right to buy) | +15,457 | 15,457 |
Page 1 of 1 · 7 trades